COR vs CAH
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
COR · Cencora$333.56 ▼ 1.80%
CAH · Cardinal Health$271.72 ▲ 1.46%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- COR -7.8%
- CAH +33.5%
Head to head
| Metric | COR | CAH |
|---|---|---|
| Price | $333.56 | $271.72 |
| Change today | ▼ 1.80% | ▲ 1.46% |
| Market cap | $63.65B | $62.80B |
| Return, 3 months | +2.8% | +14.8% |
| Return, year to date | -0.7% | +33.5% |
| Return, 1 year | -6.8% | +34.7% |
| P/E (TTM) | 18.6 | 35.2 |
| P/B | 17.3 | -20.8 |
| P/E percentile vs own 5y | 56th | 72nd |
| Dividend yield | 0.72% | 0.76% |
| Revenue growth (YoY, latest qtr) | +5.1% | +5.8% |
| Net profit growth (YoY) | +12.6% | +64.6% |
| Gross margin | 4.0% | 3.8% |
| Operating margin | 1.4% | 1.2% |
| Net margin | 0.8% | 0.7% |
| Return on equity | 104.3% | – |
| Analyst target vs. price | +13.6% | +4.8% |
| Analyst buy share | 82% | 86% |
| RSI (14) | 52 | 74 |
| 30-day volatility | 26.9% | 25.7% |
| Max drawdown, 1 year | -32.4% | -20.4% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- COR is the largest of the group by market value.
- CAH has returned the most over the past year.
- COR carries the lowest trailing P/E.
- CAH pays the highest dividend yield.
- CAH is growing revenue fastest.
- COR keeps the most profit per dollar of sales.
- CAH has been the calmest stock over the last 30 days.